182 related articles for article (PubMed ID: 18593991)
21. ALT-associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas.
Venturini L; Erdas R; Costa A; Gronchi A; Pilotti S; Zaffaroni N; Daidone M
J Pathol; 2008 Mar; 214(4):410-4. PubMed ID: 18085522
[TBL] [Abstract][Full Text] [Related]
22. Telomere length is a prognostic factor in neuroblastoma.
Ohali A; Avigad S; Ash S; Goshen Y; Luria D; Feinmesser M; Zaizov R; Yaniv I
Cancer; 2006 Sep; 107(6):1391-9. PubMed ID: 16917952
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma.
Else T; Giordano TJ; Hammer GD
J Clin Endocrinol Metab; 2008 Apr; 93(4):1442-9. PubMed ID: 18198226
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer survival is associated with telomere length in peripheral blood cells.
Svenson U; Nordfjäll K; Stegmayr B; Manjer J; Nilsson P; Tavelin B; Henriksson R; Lenner P; Roos G
Cancer Res; 2008 May; 68(10):3618-23. PubMed ID: 18483243
[TBL] [Abstract][Full Text] [Related]
25. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
26. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Wang Y; Fang M; Sun X; Sun J
Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
[TBL] [Abstract][Full Text] [Related]
27. Telomere length maintenance--an ALTernative mechanism.
Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
[TBL] [Abstract][Full Text] [Related]
28. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity in pleural malignant mesotheliomas.
Au AY; Hackl T; Yeager TR; Cohen SB; Pass HI; Harris CC; Reddel RR
Lung Cancer; 2011 Sep; 73(3):283-8. PubMed ID: 21277646
[TBL] [Abstract][Full Text] [Related]
30. Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres.
Akimcheva S; Zellinger B; Riha K
Cytogenet Genome Res; 2008; 122(3-4):388-95. PubMed ID: 19188710
[TBL] [Abstract][Full Text] [Related]
31. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
32. [Expression of hRad21 and clinicopathological analysis in gastrointestinal malignant tumors maintained their telomeres by a mechanism of alternative lengthening of telomeres].
Yi BQ; Zhao B; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):67-71. PubMed ID: 18197499
[TBL] [Abstract][Full Text] [Related]
33. [Two cases of malignant mesothelioma of the pleura within one family].
Nalepa P; Zieliński M
Pol Merkur Lekarski; 2001 Aug; 11(62):165-8. PubMed ID: 11757221
[TBL] [Abstract][Full Text] [Related]
34. P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma.
Borczuk AC; Taub RN; Hesdorffer M; Hibshoosh H; Chabot JA; Keohan ML; Alsberry R; Alexis D; Powell CA
Clin Cancer Res; 2005 May; 11(9):3303-8. PubMed ID: 15867227
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
36. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
37. Telomere maintenance in sarcomas.
Johnson JE; Broccoli D
Curr Opin Oncol; 2007 Jul; 19(4):377-82. PubMed ID: 17545803
[TBL] [Abstract][Full Text] [Related]
38. Management of malignant pleural mesothelioma.
West SD; Lee YC
Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
[TBL] [Abstract][Full Text] [Related]
39. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
40. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
